Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India

Journal of Medical Virology

Volumn 87, Issue 2, 2015, Pages 303-309

  Jain, Parul ^a   Jain, Amita ^a   Prakash, Shantanu ^a   Khan, Danish N ^a   Singh, Desh D ^a   Kumar, Archana ^a   Moulik, Nirmalya R ^a   Chandra, Tulika ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Genotype; Hemato oncology; Human parvovirus B19; India; Parvovirus B19 DNA

Indexed keywords

IMMUNOGLOBULIN M; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ANTIBODY SPECIFICITY; APLASTIC ANEMIA; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CHRONIC MYELOID LEUKEMIA; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HUMAN; HUMAN PARVOVIRUS B19; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INDIA; MAJOR CLINICAL STUDY; MALE; PHYLOGENY; PREVALENCE; SICKLE CELL ANEMIA; THALASSEMIA; VIRUS LOAD; ADULT; BLOOD; CLASSIFICATION; COMPLICATION; GENETIC VARIABILITY; GENETICS; INFANT; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR GENETICS; PARVOVIRIDAE INFECTIONS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; VIROLOGY; YOUNG ADULT;

PARVOVIRUS;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VARIATION; GENOTYPE; HEMATOLOGIC DISEASES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INDIA; INFANT; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS, DNA; VIRAL LOAD; YOUNG ADULT;

EID: 84919835546     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24028     Document Type: Article

References (34)

1. Abe K, Kiuchi T, Tanaka K, Edamoto Y, Aiba N, Sata T. 2007. Characterization of erythrovirus B19 genomes isolated in liver tissues from patients with fulminant hepatitis and biliary atresia who underwent liver transplantation. Int J Med Sci 4:105-109.
2. Aberham C, Pendl C, Gross P, Zerlauth G, Gessner M. 2001. A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA. J Virol Methods 92:183-191.
3. Abraham M, Rudraraju R, Kannangai R, George K, Cherian T, Daniel D, Ramalingam S, Sridharan G. 2002. A pilot study on the seroprevalence of parvovirus B19 infection. Indian J Med Res 115:139-143.
4. Arya LS, Seth R, Seth T. 2009. Childhood malignancies. In: Ghai OP, Paul VK, Bagga A, editors Essential paediatrics. India: CBS Publisher. p 580-597.
5. Benjamin LA, Lewthwaite P, Vasanthapuram R, Zhao G, Sharp C, Simmonds P, Wang D, Solomon T. 2011. Human parvovirus 4 as Potential cause of Encephalitis in children, India. Emerg Infect Dis 17:1484-1487.
6. Berns K, Parrish CR. 2007. Parvoviridae. In: Knipe DM, Howley PM, editors Fields Virology. Lippincott William & Wilkins. p 2438-2477.
7. Candotti D, Etiz N, Parsyan A, Allain JP. 2004. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol 78:12169-12178.
8. Cassinotti P, Siegl G. 2000. Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual. Eur J Clin Microbiol Infect Dis 19:886-887.
9. Corcoran C, Hardie D, Yeats J, Smuts H. 2010. Genetic variants of human parvovirus b19 in South Africa: Cocirculation of three genotypes and identification of a novel subtype of genotype 1. J Clin Microbiol 48:137-142.
10. da Costa AC, Bendit I, de Oliveira AC, Kallas EG, Sabino EC, Sanabani SS. 2013. Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities. Clin Microbiol Infect 19:E31-43. doi: 10.1111/1469-0691.12058
11. Ekman A, Hokynar K, Kakkola L, Kantola K, Hedman L, Bonden H, Gessner M, Aberham C, Norja P, Miettinen S, Hedman K, Soderlund-Venermo M. 2007. Biological and immunological relations among human parvovirus b19 genotypes 1 to 3. J Virol 81:6927-6935.
12. Gallinella G, Venturoli S, Manaresi E, Musiani M, Zerbini M. 2003. B19 virus genome diversity: Epidemiological and clinical correlations. J Clin Virol 28:1-13.
13. Gustafsson I, Kaldensjo T, Lindblom A, Norbeck O, Henter JI, Tolfvenstam T, Broliden K. 2010. Evaluation of Parvovirus B19 infection in children with malignant or hematological disorders. Clin Infect Dis 50:1426-1427.
14. He M, Zhu J, Yin H, Ke L, Gao L, Pan Z, Yang X, Li W. 2012. Human immunodeficiency virus/human parvovirus B19 co-infection in blood donors and AIDS patients in Sichuan, China. Blood Transfus 10:502-514.
15. Heegaard ED, Jensen L, Hornsleth A, Schmiegelow K. 1999. The role of parvovirus 19 infection in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 16:329-334.
16. Hubschen JM, Mihneva Z, Mentis AF, Schneider F, Aboudy Y, Grossman Z, Rudich H, Kasymbekova K, Sarv I, Nedeljkovic J, Tahita MC, Tarnagda Z, Ouedraogo JB, Gerasimova AG, Moskaleva TN, Tikhonova NT, Chitadze N, Forbi JC, Faneye AO, Otegbayo JA, Charpentier E, Muller CP. 2009. Phylogenetic analysis of human Parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J Clin Microbiol 47:3735-3738.
17. Jain P, Jain A, Khan DN, Kumar M. 2013. Human parvovirus B19 associated dilated cardiomyopathy. BMJ Case Reports pii: bcr 2013010410. doi: 10.1136/bcr-2013-010410
18. Kerr JR, Barah F, Cunniffe VS, Smith J, Vallely PJ, Will AM, Wynn RF, Stevens RF, Taylor GM, Cleator GM, Eden OB. 2003. Association of acute parvovirus B19 infection with new onset of acute lymphoblastic and myeloblastic leukemia. J Clin Pathol 56:873-875.
19. Kishore J, Sen M, Kumar A, Kumar A. 2011a. A pilot study on parvovirus B19 infection in paediatric haematological malignancies. Indian J Med Res 133:407-413.
20. Kishore J, Srivastava M, Choudhary N. 2011b. Serological study on parvovirus B19 infection in multitransfused thalassemia major patients and its transmission through donor units. Asian J Transfus Sci 5:140-141.
21. Kleinman SH, Glynn SA, Lee TH, Tobler L, Montalvo L, Todd D, Kiss JE, Shyamala V, Busch MP. 2007. Prevalence and quantitation of Parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion 47: 1756-1764.
22. Lefrere JJ, Servant-Delmas A, Candotti D, Mariotti M, Thomas I, Brossard Y, Lefrere F, Girot R, Allain JP, Laperche S. 2005. Persistent B19 infection in immunocompetent individuals: Implications for transfusion safety. Blood 106:2890-2895.
23. Mishra B, Malhotra P, Ratho RK, Singh MP, Varma S, Varma N. 2005. Human Parvovirus B19 in patients with aplastic anaemia. Am J Hematol 79:166-167.
24. Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, Kiviluoto O, Davidkin I, Leivo T, Eis-Hubinger AM, Schneider B, Fischer HP, Tolba R, Vapalahti O, Vaheri A, Soderlund-Venermo M, Hedman K. 2006. Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 103:7450-7453.
25. Osaki M, Matsubara K, Iwasaki T, Kurata T, Nigami H, Harigaya H, Baba K. 1999. Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease. Ann Hematol 78:83-86.
26. Parsyan A, Szmaragd C, Allain JP, Candotti D. 2007. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol 88:428-431.
27. Qian XH, Zhang GC, Jiao XY, Zheng YJ, Cao YH, Xu DL, Chen CS. 2002. Aplastic anaemia associated with parvovirus B19 infection. Arch Dis Child 87:436-437.
28. Regaya F, Oussaief L, Bejaoui M, Karoui M, Zili M, Khelifa R. 2007. Parvovirus B19 infection in Tunisian patients with sickle-cell anaemia and acute erythroblastopenia. BMC Infect Dis 7:123-129.
29. Sanabani S, Neto WK, Pereira J, Sabino EC. 2006. Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms. J Clin Microbiol 44:604-606.
30. Schmidt I, Blumel J, Seitz H, Willkommen H, Lower J. 2001. Parvovirus B19 DNA in plasma pools and plasma derivatives. Vox Sang 81:228-235.
31. Slavov SN, Kashima S, Pinto AC, Covas DT. 2011. Human parvovirus B19: General considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions. FEMS Immunol Med Microbiol 62:247-262.
32. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEG A5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731-2739.
33. Toan NL, Duechting A, Kremsner PG, Song le H, Ebinger M, Aberle S, Binh VQ, Duy DN, Torresi J, Kandolf R, Bock CT. 2006. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J Gen Virol 87:2941-2949.
34. Zaki Mel S, Hassan SA, Seleim T, Lateef RA. 2006. Parvovirus B19 infection in children with a variety of hematological disorders. Hematology 11:261-266.